BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,819,544 | +54.9% | 366,717 | +105.7% | 0.00% | 0.0% |
| Q2 2023 | $5,692,671 | -50.8% | 178,286 | -52.8% | 0.00% | 0.0% |
| Q1 2023 | $11,562,724 | +80.1% | 377,620 | +130.1% | 0.00% | 0.0% |
| Q4 2022 | $6,418,655 | +12.5% | 164,118 | +37.0% | 0.00% | 0.0% |
| Q3 2022 | $5,705,000 | +6.6% | 119,775 | -13.4% | 0.00% | 0.0% |
| Q2 2022 | $5,353,000 | -32.2% | 138,260 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $7,891,000 | -9.4% | 137,713 | +26.0% | 0.00% | 0.0% |
| Q4 2021 | $8,708,000 | +474.8% | 109,263 | +527.2% | 0.00% | – |
| Q3 2021 | $1,515,000 | -56.8% | 17,422 | -36.0% | 0.00% | – |
| Q2 2021 | $3,506,000 | +119.7% | 27,235 | +36.6% | 0.00% | – |
| Q1 2021 | $1,596,000 | +114.8% | 19,940 | +119.1% | 0.00% | – |
| Q4 2020 | $743,000 | +569.4% | 9,102 | +101.7% | 0.00% | – |
| Q3 2020 | $111,000 | -54.3% | 4,512 | -48.0% | 0.00% | – |
| Q2 2020 | $243,000 | +107.7% | 8,676 | +33.0% | 0.00% | – |
| Q1 2020 | $117,000 | – | 6,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |